Compare MINISO Group Holding Ltd (MNSO) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MINISO Group Holding Ltd vs Novo Nordisk A/S — how do they compare? MINISO Group Holding Ltd trades at $12.46 (market cap $3.87B), while Novo Nordisk A/S trades at $49.35 (market cap $220.53B). The key difference: Novo Nordisk A/S is far larger — about 57× MINISO Group Holding Ltd's market cap, and MINISO Group Holding Ltd pays the higher dividend (5.21%). Which is the better fit depends on your goals.
| MNSO | NVO | |
|---|---|---|
Market Cap | $3.87B | $220.53B |
Sector | Technology | Health |
52-Week High | $26.63 | $71.70 |
52-Week Low | $11.30 | $35.29 |
Enterprise Value | $4.54B | $239.49B |
Dividend Yield | 5.21% | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
